INS and type 1 diabetes mellitus: Considering in particular the latter, islet encapsulation in hydrogels has been studied for more than two decades as a potential treatment of type I diabetes mellitus, with the intent of keeping the implanted cells safe from the recipient ́s immune system while keeping them active and producing insulin as needed [6,43].